Director/PDMR Shareholding

RNS Number : 2743K

GlaxoSmithKline PLC

12 July 2011

 



 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and the under-mentioned persons on 12 July 2011 of an increase in their notional interests in Ordinary shares at a price of 1366.50 pence per Ordinary share and ADRs at a price of $43.91 per ADR following the notional re-investment of the dividend paid to shareholders on 7 July 2011.

	Ordinary shares	ADRs
Mr A P Witty	16,126.401
Dr M M Slaoui		4,323.445
Mr S M Bicknell	1,434.575
Mr J M Clarke	4,015.251
Mrs D P Connelly		2,544.286
Mr M Dunoyer	1,887.406
Mr E J Gray	3,030.207
Mr S A Hussain	3,961.933
Mr W C Louv		1,304.354
Dr D Pulman		1,954.980
Mr D S Redfern	1,848.253
Mr J R Stéphenne	2,322.273
Ms C Thomas	2,664.210
Mr P C Thomson	215.137
Mr D E Troy		2,580.684
Dr P J T Vallance	2,617.960
Ms E Walmsley	1,557.579
Mrs V A Whyte	215.137

The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rules 3.1.4R(1)(a).

V A Whyte

Company Secretary

12 July 2011

 

END

 

 

RDSQLLFFFDFXBBL